AstraZeneca, FibroGen’s roxadustat hit with tough safety questions in FDA review ahead of key expert meetingnews2021-07-13T15:16:36+00:00July 13th, 2021|Fierce Pharma|
Sanofi inks national Olympic sponsorship for Paris 2024, reinforces social and environmental goalsnews2021-07-13T14:11:01+00:00July 13th, 2021|Fierce Pharma|
Sanofi joins the Paris 2024 team, inking a $94M-plus national Olympic sponsorshipnews2021-07-13T14:11:01+00:00July 13th, 2021|Fierce Pharma|
Ena starts phase 1 trial of COVID-19-preventing nasal spraynews2021-07-13T14:08:29+00:00July 13th, 2021|Fierce Pharma|
Curia, on heels of rebrand, snaps up CDMO Integrity Bio to expand westwardnews2021-07-13T13:34:17+00:00July 13th, 2021|Fierce Pharma|
Fresenius launches ready-to-administer prefilled fentanyl syringe news2021-07-13T12:38:27+00:00July 13th, 2021|Fierce Pharma|
Opiant’s nasal opioid overdose drug clears clinical test ahead of planned FDA filingnews2021-07-13T12:31:56+00:00July 13th, 2021|Fierce Pharma|
U.K. makes novel vaccine delivery a focus of life science plans news2021-07-13T12:26:23+00:00July 13th, 2021|Fierce Pharma|
Guardant nabs chief commercial officer from Gilead as it preps more ‘liquid biopsy’ rolloutsnews2021-07-13T00:13:34+00:00July 13th, 2021|Fierce Pharma|
Gilead’s Veklury shows ‘no antiviral effects’ against COVID-19 in small WHO studynews2021-07-12T18:59:36+00:00July 12th, 2021|Fierce Pharma|
